UPDATE 1-Camber Capital to discuss Amag's board composition with shareholders
September 20, 2019 at 08:44 AM EDT
Camber Capital Management on Friday reported a stake of about 13% in Amag Pharmaceuticals Inc and said it intends to discuss the composition of the drugmaker's board with shareholders, weeks after another investor called for changes at the company.
